Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Point-of-Care Molecular Diagnostics market report explains the definition, types, applications, major countries, and major players of the Point-of-Care Molecular Diagnostics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Bayer AG
Becton Dickinson Co
Novartis AG
Danaher Corporation
Bio-Rad Laboratories Inc
Qiagen
Alere Inc
Siemens Healthcare GmbH
By Type:
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
By End-User:
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Point-of-Care Molecular Diagnostics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Point-of-Care Molecular Diagnostics Outlook to 2028- Original Forecasts
-
2.2 Point-of-Care Molecular Diagnostics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Point-of-Care Molecular Diagnostics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Point-of-Care Molecular Diagnostics Market- Recent Developments
-
6.1 Point-of-Care Molecular Diagnostics Market News and Developments
-
6.2 Point-of-Care Molecular Diagnostics Market Deals Landscape
7 Point-of-Care Molecular Diagnostics Raw Materials and Cost Structure Analysis
-
7.1 Point-of-Care Molecular Diagnostics Key Raw Materials
-
7.2 Point-of-Care Molecular Diagnostics Price Trend of Key Raw Materials
-
7.3 Point-of-Care Molecular Diagnostics Key Suppliers of Raw Materials
-
7.4 Point-of-Care Molecular Diagnostics Market Concentration Rate of Raw Materials
-
7.5 Point-of-Care Molecular Diagnostics Cost Structure Analysis
-
7.5.1 Point-of-Care Molecular Diagnostics Raw Materials Analysis
-
7.5.2 Point-of-Care Molecular Diagnostics Labor Cost Analysis
-
7.5.3 Point-of-Care Molecular Diagnostics Manufacturing Expenses Analysis
8 Global Point-of-Care Molecular Diagnostics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Point-of-Care Molecular Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Point-of-Care Molecular Diagnostics Export by Region (Top 10 Countries) (2017-2028)
9 Global Point-of-Care Molecular Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Point-of-Care Molecular Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PCR-based Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Genetic Sequencing-based Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hybridization-based Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Microarray-based Consumption and Growth Rate (2017-2022)
-
9.2 Global Point-of-Care Molecular Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hematology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prenatal Testing Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Endocrinology Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Point-of-Care Molecular Diagnostics Market Analysis and Outlook till 2022
-
10.1 Global Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.2.2 Canada Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.2.3 Mexico Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.2 UK Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.3 Spain Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.4 Belgium Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.5 France Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.6 Italy Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.7 Denmark Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.8 Finland Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.9 Norway Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.10 Sweden Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.11 Poland Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.12 Russia Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.3.13 Turkey Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.2 Japan Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.3 India Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.4 South Korea Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.5 Pakistan Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.6 Bangladesh Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.7 Indonesia Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.8 Thailand Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.9 Singapore Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.10 Malaysia Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.11 Philippines Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.4.12 Vietnam Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.2 Colombia Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.3 Chile Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.4 Argentina Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.5 Venezuela Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.6 Peru Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.7 Puerto Rico Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.5.8 Ecuador Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.6.2 Kuwait Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.6.3 Oman Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.6.4 Qatar Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.7.2 South Africa Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.7.3 Egypt Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.7.4 Algeria Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
10.8.2 New Zealand Point-of-Care Molecular Diagnostics Consumption (2017-2022)
11 Global Point-of-Care Molecular Diagnostics Competitive Analysis
-
11.1 Bayer AG
-
11.1.1 Bayer AG Company Details
-
11.1.2 Bayer AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Bayer AG Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.1.4 Bayer AG Point-of-Care Molecular Diagnostics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Becton Dickinson Co
-
11.2.1 Becton Dickinson Co Company Details
-
11.2.2 Becton Dickinson Co Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Becton Dickinson Co Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.2.4 Becton Dickinson Co Point-of-Care Molecular Diagnostics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novartis AG
-
11.3.1 Novartis AG Company Details
-
11.3.2 Novartis AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novartis AG Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.3.4 Novartis AG Point-of-Care Molecular Diagnostics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Danaher Corporation
-
11.4.1 Danaher Corporation Company Details
-
11.4.2 Danaher Corporation Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Danaher Corporation Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.4.4 Danaher Corporation Point-of-Care Molecular Diagnostics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Bio-Rad Laboratories Inc
-
11.5.1 Bio-Rad Laboratories Inc Company Details
-
11.5.2 Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.5.4 Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Qiagen
-
11.6.1 Qiagen Company Details
-
11.6.2 Qiagen Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Qiagen Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.6.4 Qiagen Point-of-Care Molecular Diagnostics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Alere Inc
-
11.7.1 Alere Inc Company Details
-
11.7.2 Alere Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Alere Inc Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.7.4 Alere Inc Point-of-Care Molecular Diagnostics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Siemens Healthcare GmbH
-
11.8.1 Siemens Healthcare GmbH Company Details
-
11.8.2 Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
11.8.4 Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
12 Global Point-of-Care Molecular Diagnostics Market Outlook by Types and Applications to 2028
-
12.1 Global Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global PCR-based Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Genetic Sequencing-based Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Hybridization-based Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Microarray-based Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Point-of-Care Molecular Diagnostics Market Analysis and Outlook to 2028
-
13.1 Global Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.2.2 Canada Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.2 UK Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.3 Spain Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.5 France Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.6 Italy Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.8 Finland Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.9 Norway Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.11 Poland Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.12 Russia Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.2 Japan Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.3 India Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.3 Chile Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.6 Peru Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.3 Oman Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Point-of-Care Molecular Diagnostics
-
Figure of Point-of-Care Molecular Diagnostics Picture
-
Table Global Point-of-Care Molecular Diagnostics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Point-of-Care Molecular Diagnostics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global PCR-based Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Sequencing-based Consumption and Growth Rate (2017-2022)
-
Figure Global Hybridization-based Consumption and Growth Rate (2017-2022)
-
Figure Global Microarray-based Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Hematology Consumption and Growth Rate (2017-2022)
-
Figure Global Prenatal Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Endocrinology Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Table North America Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure United States Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Canada Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Germany Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure UK Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Spain Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure France Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Italy Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Finland Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Norway Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Poland Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Russia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table APAC Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure China Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table South America Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Brazil Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Chile Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Peru Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table GCC Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Bahrain Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Oman Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Africa Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Nigeria Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Oceania Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure Australia Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Bayer AG Company Details
-
Table Bayer AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Bayer AG Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Becton Dickinson Co Company Details
-
Table Becton Dickinson Co Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson Co Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Becton Dickinson Co Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Novartis AG Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Danaher Corporation Company Details
-
Table Danaher Corporation Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Danaher Corporation Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Bio-Rad Laboratories Inc Company Details
-
Table Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Qiagen Company Details
-
Table Qiagen Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Qiagen Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Alere Inc Company Details
-
Table Alere Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alere Inc Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Alere Inc Point-of-Care Molecular Diagnostics Product Portfolio
-
Table Siemens Healthcare GmbH Company Details
-
Table Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Main Business and Markets Served
-
Table Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Product Portfolio
-
Figure Global PCR-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Sequencing-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hybridization-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microarray-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Table North America Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Germany Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure China Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure Australia Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
